Orion Corporation
From Wikipedia, the free encyclopedia
 |
|
| Type | Public (OMX: ORNBV) |
|---|---|
| Founded | 1917 |
| Headquarters | Espoo, Finland |
| Key people | Timo Lappalainen (President and CEO), Matti Kavetvuo (Chairman of the board) |
| Industry | Pharmaceutical industry |
| Products | Pharmaceuticals, active pharmaceutical ingredients and diagnostic tests |
| Revenue | €710.7 million (2008)[1] |
| Operating income | ▲ €185.0 million (2008)[1] |
| Profit | ▲ €136.3 million (2008)[1] |
| Employees | 3,310 (2008)[1] |
| Website | www.orion.fi |
Orion Corporation, founded in 1917 and headquartered at Espoo, Finland, is a Finnish company, which develops, manufactures and markets pharmaceuticals, active pharmaceutical ingredients and diagnostic tests for global markets. The company has also a large R&D unit in Turku.
Orion has annual net sales of approximately EUR 500 million; its class A and B shares are listed on the Helsinki Stock Exchange.
[edit] References
- ^ a b c d "Annual Results 2008". Orion. http://img.orion.fi/liitteet/204184.pdf. Retrieved on 2009-03-09.
[edit] External links
|
|||||
